Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

Visualizza tutta la documentazione

193038

Sigma-Aldrich

Borane dimethyl sulfide complex solution

1.0 M in methylene chloride

Sinonimo/i:

BMS, Trihydro[thiobis[methane]]boron

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula condensata:
(CH3)2S · BH3
Numero CAS:
13292-87-0
Peso molecolare:
75.97
Beilstein:
3663489
Numero MDL:
MFCD00013189
Codice UNSPSC:
12352112
ID PubChem:
24851577

Stato

liquid

Impiego in reazioni chimiche

reagent type: reductant

Concentrazione

1.0 M in methylene chloride

Densità

1.287 g/mL at 25 °C

Temperatura di conservazione

2-8°C

Stringa SMILE

B.CSC

InChI

1S/C2H6S.BH3/c1-3-2;/h1-2H3;1H3
RMHDLBZYPISZOI-UHFFFAOYSA-N

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Applicazioni

Reactant used as a regioselective reducing agent

Reactant involved in:
  • Hydroboration / oxidation
Synthesis of cage compounds

Avvertenze

Danger

Classi di pericolo

Acute Tox. 4 Oral - Carc. 2 - Eye Dam. 1 - Flam. Liq. 2 - Repr. 1B - Skin Irrit. 2 - STOT SE 3 - Water-react 2

Organi bersaglio

Central nervous system

Classe di pericolosità dell'acqua (WGK)

WGK 2

Dispositivi di protezione individuale

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number
11497TJV
11497TJ
S43099
S41392
00312PE

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Cerca un COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

A Burchert et al.
Leukemia, 29(6), 1331-1335 (2015-02-26)
A minority of chronic myeloid leukemia (CML) patients is capable of successfully discontinuing imatinib. Treatment modalities to increase this proportion are currently unknown. Here, we assessed the role of interferon alpha 2a (IFN) on therapy discontinuation in a previously reported
Andrew J Saykin et al.
Alzheimer's & dementia : the journal of the Alzheimer's Association, 11(7), 792-814 (2015-07-22)
Genetic data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) have been crucial in advancing the understanding of Alzheimer's disease (AD) pathophysiology. Here, we provide an update on sample collection, scientific progress and opportunities, conceptual issues, and future plans. Lymphoblastoid cell
Kathleen C Rollet-Kurhajec et al.
PloS one, 10(6), e0129868-e0129868 (2015-06-20)
In Hepatitis C virus (HCV) mono-infection, male sex is associated with faster liver fibrosis progression but the effects of sex have not been well studied in HIV-HCV co-infected patients. We examined the influence of sex on progression to significant liver
D J Hunter et al.
Osteoarthritis and cartilage, 23(5), 732-746 (2015-05-09)
Tremendous advances have occurred in our understanding of the pathogenesis of hand osteoarthritis (OA) and these are beginning to be applied to trials targeted at modification of the disease course. The purpose of this expert opinion, consensus driven exercise is
John M Kane et al.
The Journal of clinical psychiatry, 76(3), 240-246 (2015-04-02)
The premise of the National Institute of Mental Health Recovery After an Initial Schizophrenia Episode Early Treatment Program (RAISE-ETP) is to combine state-of-the-art pharmacologic and psychosocial treatments delivered by a well-trained, multidisciplinary team in order to significantly improve the functional
Visualizza tutti i documenti correlati

Questions

Reviews

No rating value

Active Filters

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.